Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin compared with capecitabine alone in locally advanced rectal cancer.
The PETACC6 study is an EORTC-led open-label, randomised, multinational two-arm phase III study investigating whether the addition of oxaliplatin to preoperative fluoropyrimidine-based chemoradiation and postoperative fluoropyrimidine-based chemotherapy improves disease-free survival in locally advanced rectal cancer.
Cancer Australia; Cancer Council NSW
Patients with locally advanced rectal cancer
Australian Lead Group:
Hans-Joachim Schmoll (international), Tim Price (Australia)